Becker's Healthcare March 5, 2024
The FDA approved a new drug for first-line lung cancer treatment.
Amivantamab-vmjw was approved with carboplatin and pemetrexed for locally advanced or metastatic non-small cell lung cancer with epidermal growth...
Becker's Healthcare March 5, 2024
The FDA approved a new drug for first-line lung cancer treatment.
Amivantamab-vmjw was approved with carboplatin and pemetrexed for locally advanced or metastatic non-small cell lung cancer with epidermal growth...